IG Guidelines on Individual Physicians and Small Practices

Publication
Article
OncologyONCOLOGY Vol 14 No 9
Volume 14
Issue 9

Individual physicians and those in small group practices are urged to begin implementing internal audit procedures for “high risk” billing operations.

Individual physicians and those in small group practices are urged to begin implementing internal audit procedures for “high risk” billing operations. This is one of the recommendations included in the “voluntary” compliance guidelines issued in draft form by the Office of the Inspector General (IG) at the Department of Health and Human Services. The IG has published similar programs for hospitals, nursing homes, and other provider groups. IG compliance programs are voluntary; a physician does not have to adopt one. A spokesperson for the IG says that providers with effective compliance programs are better assured of meeting rules and regulations for doing business with government health-care programs. By the way, the IG will not define how many physicians make a “small group.” The implication is clear: No practice is too big to be small.

Recent Videos
Efficacy results from the MASAI trial preceded the creation of the UK-funded EDITH trial, assessing 5 AI platforms in 700,000 women undergoing mammography.
Combining sotorasib with panitumumab may reduce the burden of disease in patients with KRAS G12C-mutated metastatic colorectal cancer.
6 experts are featured in this series.
6 experts are featured in this series.
Findings from the phase 2b ReNeu trial show significant pain relief with mirdametinib in adult and pediatric patients with NF1-PN.
Findings from the CodeBreak 300 study have cemented sotorasib/panitumumab as a third-line treatment option for KRAS G12C-mutated colorectal cancer.
The dispersible tablet formulation of mirdametinib may offer convenience to patients with NF1-PN and difficulty with swallowing pills.
Related Content